264 related articles for article (PubMed ID: 20660683)
1. An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant.
García-Fernández A; Miriagou V; Papagiannitsis CC; Giordano A; Venditti M; Mancini C; Carattoli A
Antimicrob Agents Chemother; 2010 Oct; 54(10):4178-84. PubMed ID: 20660683
[TBL] [Abstract][Full Text] [Related]
2. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.
Wang XD; Cai JC; Zhou HW; Zhang R; Chen GX
J Med Microbiol; 2009 Sep; 58(Pt 9):1196-1202. PubMed ID: 19528170
[TBL] [Abstract][Full Text] [Related]
3. Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant.
Poulou A; Voulgari E; Vrioni G; Koumaki V; Xidopoulos G; Chatzipantazi V; Markou F; Tsakris A
J Clin Microbiol; 2013 Oct; 51(10):3176-82. PubMed ID: 23850951
[TBL] [Abstract][Full Text] [Related]
4. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
[TBL] [Abstract][Full Text] [Related]
5. Role of association of OmpK35 and OmpK36 alteration and bla
Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
[TBL] [Abstract][Full Text] [Related]
6. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
[TBL] [Abstract][Full Text] [Related]
8. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D
Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596
[TBL] [Abstract][Full Text] [Related]
9. Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.
Leavitt A; Chmelnitsky I; Colodner R; Ofek I; Carmeli Y; Navon-Venezia S
J Clin Microbiol; 2009 Apr; 47(4):969-74. PubMed ID: 19213695
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.
Doumith M; Ellington MJ; Livermore DM; Woodford N
J Antimicrob Chemother; 2009 Apr; 63(4):659-67. PubMed ID: 19233898
[TBL] [Abstract][Full Text] [Related]
11. An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia.
Hamzaoui Z; Ocampo-Sosa A; Maamar E; Fernandez Martinez M; Ferjani S; Hammami S; Harbaoui S; Genel N; Arlet G; Saidani M; Slim A; Boutiba-Ben Boubaker I; Martinez-Martinez L
Microb Drug Resist; 2018 Oct; 24(8):1137-1147. PubMed ID: 29373087
[TBL] [Abstract][Full Text] [Related]
12. Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production.
Shi W; Li K; Ji Y; Jiang Q; Wang Y; Shi M; Mi Z
Braz J Microbiol; 2013; 44(2):435-42. PubMed ID: 24294234
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
14. Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones.
Novais A; Rodrigues C; Branquinho R; Antunes P; Grosso F; Boaventura L; Ribeiro G; Peixe L
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3057-63. PubMed ID: 22706513
[TBL] [Abstract][Full Text] [Related]
15. Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.
Hong JH; Clancy CJ; Cheng S; Shields RK; Chen L; Doi Y; Zhao Y; Perlin DS; Kreiswirth BN; Nguyen MH
Antimicrob Agents Chemother; 2013 May; 57(5):2147-53. PubMed ID: 23459476
[TBL] [Abstract][Full Text] [Related]
16. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results.
Carvalhaes CG; Picão RC; Nicoletti AG; Xavier DE; Gales AC
J Antimicrob Chemother; 2010 Feb; 65(2):249-51. PubMed ID: 19996141
[TBL] [Abstract][Full Text] [Related]
17. Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy.
Findlay J; Hamouda A; Dancer SJ; Amyes SG
Clin Microbiol Infect; 2012 Feb; 18(2):140-6. PubMed ID: 21745255
[TBL] [Abstract][Full Text] [Related]
18. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.
Kaczmarek FM; Dib-Hajj F; Shang W; Gootz TD
Antimicrob Agents Chemother; 2006 Oct; 50(10):3396-406. PubMed ID: 17005822
[TBL] [Abstract][Full Text] [Related]
19. Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae.
Kitchel B; Rasheed JK; Endimiani A; Hujer AM; Anderson KF; Bonomo RA; Patel JB
Antimicrob Agents Chemother; 2010 Oct; 54(10):4201-7. PubMed ID: 20660684
[TBL] [Abstract][Full Text] [Related]
20. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
Cai JC; Zhou HW; Zhang R; Chen GX
Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]